Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxidants/antioxidants and COPD.

W MacNee1

  • 1Edinburgh Lung Environmental Group Initiative, Colt Research Laboratories, University of Edinburgh, Edinburgh, Scotland, UK. w.macnee@ed.ac.uk

Chest
|June 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same author

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

The journal of nutrition, health & aging·2016
Same author

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2016
Same author

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.

The pharmacogenomics journal·2015
Same author

Systemic Effect of Particulate Air Pollution.

Inhalation toxicology·2015
Same journal

Redefining ILD Diagnosis Through the Bronchoscope: Molecular and Imaging Innovations.

Chest·2026
Same journal

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026
Same journal

Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.

Chest·2026
Same journal

Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.

Chest·2026
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
See all related articles

Oxidative stress, an imbalance of oxidants and antioxidants, significantly contributes to chronic obstructive pulmonary disease (COPD) pathogenesis and inflammation. Antioxidant supplementation may offer therapeutic benefits for COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Oxidative Stress Research
  • Inflammation Biology

Background:

  • Oxidative stress arises from an imbalance between oxidants and antioxidants.
  • It is implicated in the pathogenesis of lung diseases, including COPD, by affecting inflammation.
  • Increased oxidative stress markers are observed in smokers and COPD patients.

Purpose of the Study:

  • To explore the role of oxidative stress in COPD pathogenesis.
  • To investigate the mechanisms by which oxidative stress influences lung inflammation in COPD.
  • To assess the potential therapeutic benefits of antioxidants in COPD.

Main Methods:

  • Review of existing studies on oxidative stress markers in smokers and COPD patients.
  • Analysis of the molecular mechanisms linking oxidative stress to inflammation.

Related Experiment Videos

  • Examination of the relationship between antioxidant levels and airflow limitation.

    • Main Results:

    • Oxidative stress contributes to COPD through antiproteinase inactivation, epithelial injury, and enhanced inflammation.
    • Redox-sensitive transcription factors (NF-κB, AP-1) are activated by oxidative stress, regulating inflammatory gene expression.
    • Sources of oxidative stress include cigarette smoke and leukocyte-derived reactive oxygen species.

    Conclusions:

    • Oxidative stress is a key factor in COPD pathogenesis and inflammation.
    • Antioxidant deficiency may contribute to airflow limitation.
    • Dietary antioxidant supplementation and therapies with antioxidant properties show therapeutic potential for COPD.